Printable version (PDF) 

TAXATION

– Clinical trials, Special Report, 733
– Offsetting costs with tax credits and incentives, BNA Insights, 505
– R&D credit extension

See LEGISLATION, FEDERAL, HR 4213, S 1203

TERRORISM

– Biodefense chief needed, 617
– Boston biocontainment lab evaluation, 754
– Detecting biological events, GAO recommendations, 16
– Dual use

– – Life scientists educational materials, 583
– – Transparency and stakeholder education, 615

– Emergency countermeasures, HHS strategy, 554
– Ft. Dietrick biocontainment labs environmental impact, 181
– Ideological approaches to developing countermeasures, 281
– Options for Congress, CRS reports, 520
– Project BioShield challenges, CRS report, 78; update, 455
– Sequence-based system urged, 519
– Shortcomings in DHS lab assessment, 753

TEXAS

– Cancer

– – Funding, 84; rules, 525
– – Prevention and Research Inst., 26; rules issued, 148

– Conflicts of interest rules, 26
– Privacy, newborn blood collection settlement (W.D. Tex.), 25

TROVAN

– Antibiotic clinical trial injuries (U.S., brief filed), 368; (rev den), 401; limited discovery (S.D.N.Y.), 689
– Nigerian settlement disbursement ground rules, 73

Contact the Webmaster at webmaster@bna.com
1801 S. Bell Street, Arlington, VA 22202 - Phone: 1-800-372-1033

Copyright © The Bureau of National Affairs, Inc. All Rights Reserved.